Jin Yang

2.3k total citations
87 papers, 1.5k citations indexed

About

Jin Yang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jin Yang has authored 87 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 34 papers in Molecular Biology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jin Yang's work include Cancer-related Molecular Pathways (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cardiac Arrest and Resuscitation (7 papers). Jin Yang is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cardiac Arrest and Resuscitation (7 papers). Jin Yang collaborates with scholars based in China, United States and Czechia. Jin Yang's co-authors include William N. Hait, Elizabeth Alli, W N Hait, Wu Xiao-Hua, Hongguang Zhu, Hao Wu, Zu‐De Xu, Xianming Hu, Yuling Xiao and Xianran He and has published in prestigious journals such as Circulation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jin Yang

81 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jin Yang China	23	861	606	297	237	228	87	1.5k
Evgeny V. Denisov Russia	22	679 0.8×	700 1.2×	494 1.7×	236 1.0×	214 0.9×	92	1.6k
Wilberto Nieves‐Neira United States	17	1.2k 1.4×	671 1.1×	254 0.9×	146 0.6×	138 0.6×	29	1.7k
Janeen H. Trembley United States	23	1.3k 1.5×	611 1.0×	187 0.6×	251 1.1×	165 0.7×	72	1.9k
Hassan Lemjabbar‐Alaoui United States	11	787 0.9×	354 0.6×	280 0.9×	250 1.1×	319 1.4×	17	1.4k
Ran Zhao United States	25	1.2k 1.3×	520 0.9×	367 1.2×	117 0.5×	213 0.9×	72	1.7k
Xiaobing Deng United States	24	1.2k 1.4×	436 0.7×	300 1.0×	154 0.6×	222 1.0×	39	1.8k
Chi-Hung Huang Taiwan	15	1.2k 1.4×	713 1.2×	497 1.7×	156 0.7×	127 0.6×	27	1.8k
Sven A. Lang Germany	24	928 1.1×	449 0.7×	298 1.0×	121 0.5×	174 0.8×	44	1.5k
Sheng-Chieh Hsu Taiwan	16	1.0k 1.2×	811 1.3×	364 1.2×	119 0.5×	286 1.3×	16	1.7k
Edward K. Han United States	26	1.2k 1.4×	764 1.3×	233 0.8×	228 1.0×	170 0.7×	32	1.9k

Countries citing papers authored by Jin Yang

Since Specialization

Citations

This map shows the geographic impact of Jin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Yang more than expected).

Fields of papers citing papers by Jin Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Yang. The network helps show where Jin Yang may publish in the future.

Co-authorship network of co-authors of Jin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Yang. A scholar is included among the top collaborators of Jin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Yang. Jin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yan, et al.. (2025). Invasive lobular carcinoma of the breast: metastatic patterns and treatment modalities—a review. Frontiers in Oncology. 15. 1631670–1631670.

Fan, Ying, Qingyuan Zhang, Min Yan, et al.. (2025). Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: a phase Ib study. Nature Communications. 16(1). 3–3. 3 indexed citations

Liu, Yingwei, et al.. (2024). Beta-Myrcene as a Sedative–Hypnotic Component from Lavender Essential Oil in DL-4-Chlorophenylalanine-Induced-Insomnia Mice. Pharmaceuticals. 17(9). 1161–1161. 3 indexed citations

Li, Huilin, Jin Yang, Jiawen Yao, et al.. (2024). 438TiP Trastuzumab deruxtecan with pyrotinib in first-line HER2-positive unresectable or metastatic breast cancer: An exploratory, multi-center, single-arm, phase II study (TROPHY, trial in progress). Annals of Oncology. 35. S404–S405. 1 indexed citations

Xu, Jiao, et al.. (2024). Xenograft and organoid models in developing precision medicine for gastric cancer (Review). International Journal of Oncology. 64(4). 1 indexed citations

Xu, Binghe, Fei Ma, Tao Wang, et al.. (2023). A Phase IIb, single arm, multicenter trial of sacituzumab govitecan in Chinese patients with metastatic triple‐negative breast cancer who received at least two prior treatments. International Journal of Cancer. 152(10). 2134–2144. 27 indexed citations

Su, Yan, Jin Yang, Mengmeng Wang, et al.. (2023). Cyclometalated iridium(III) complexes as anti-breast cancer and anti-metastasis agents via STAT3 inhibition. Journal of Inorganic Biochemistry. 251. 112427–112427. 15 indexed citations

Su, Yan, Hai Lin, Ying Tu, et al.. (2022). Fighting metallodrug resistance through alteration of drug metabolism and blockage of autophagic flux by mitochondria-targeting AIEgens. Chemical Science. 13(5). 1428–1439. 24 indexed citations

Zhou, Yan, Qi Tian, Huan Gao, et al.. (2022). Correlation Between Immune-Related Genes and Tumor-Infiltrating Immune Cells With the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer. Frontiers in Genetics. 13. 905617–905617. 6 indexed citations

10.

Zhang, Juan, Qi Tian, Mi Zhang, et al.. (2021). Immune-related biomarkers in triple-negative breast cancer. Breast Cancer. 28(4). 792–805. 31 indexed citations

11.

Zheng, Guanghui, Jingying Hou, Qin Ling, et al.. (2020). N-acetylcysteine alleviates post-resuscitation myocardial dysfunction and improves survival outcomes via partly inhibiting NLRP3 inflammasome induced-pyroptosis. Journal of Inflammation. 17(1). 25–25. 23 indexed citations

12.

Yang, Jiao, Xiaoman Zhang, Zheling Chen, et al.. (2019). Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer. Cell Death and Disease. 10(3). 179–179. 14 indexed citations

13.

Chen, Zheling, Jiao Yang, Yanwei Shen, et al.. (2018). AmotP130 regulates Rho GTPase and decreases breast cancer cell mobility. Journal of Cellular and Molecular Medicine. 22(4). 2390–2403. 6 indexed citations

14.

Yang, Jin, Weiping Huang, Xiaobo Wu, et al.. (2017). Abstract 18399: Polyethylene Glycol-20k Improves Microcirculation in a Rat Model of Cardiopulmonary Resuscitation. Circulation. 1 indexed citations

15.

Yang, Jin, Weiping Huang, Xiaobo Wu, et al.. (2017). Abstract 16699: Effects of Polyethylene Glycol-20K on Post-Resuscitation Survival and Neurological Function in a Rat Model of Cardiopulmonary Resuscitation. Circulation. 136. 1 indexed citations

16.

Yang, Jin, Weiping Huang, Xiaobo Wu, et al.. (2017). Abstract 16835: Effects of Polyethylene Glycol-20K on Postresuscitation Myocardial Function in a Rat Model of Cardiopulmonary Resuscitation. Circulation. 1 indexed citations

17.

Chen, Aili, Yixin Hu, Xinchang Zheng, et al.. (2017). Clinical Outcomes and Mutation Clearance in Children with Acute Myeloid Leukemia Treated with Low-Dose Chemotherapy Plus G-CSF for Remission Induction. Blood. 130. 1397–1397. 2 indexed citations

18.

He, Xianran, Min Zhong, Tao Zhang, et al.. (2010). Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives. European Journal of Medicinal Chemistry. 45(12). 5870–5877. 17 indexed citations

19.

Rozowsky, Joel, Daniel E. Newburger, Jiaqian Wu, et al.. (2007). The DART classification of unannotated transcription within the ENCODE regions: Associating transcription with known and novel loci. Genome Research. 17(6). 732–745. 20 indexed citations

20.

Sullivan, Gregory F., et al.. (1998). The expression of drug resistance gene products during the progression of human prostate cancer.. PubMed. 4(6). 1393–403. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact